Eric Devroe
Chief Operating Officer at Acrivon Therapeutics, Inc. (ACRV)
Eric Devroe has filed 16 insider reports with the SEC since May 2024, as chief Operating Officer at Acrivon Therapeutics, Inc. (ACRV). In the last 12 months Eric Devroe bought $17.2K and sold $1,214 of stock on the open market. In the latest filing, on August 20, 2026, Eric Devroe sold 604 shares of Acrivon Therapeutics, Inc. (ACRV) for $1,214 at an average of $2.01.
- Filings
- 16
- Companies
- 1
- Bought on market
- $17.2K
- Sold on market
- $1,214
Companies where Eric Devroe is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | Chief Operating Officer | 146,349 | $17.2K | $1,214 | $1.72 | $1.61-6.4% | Aug 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Aug 18, 2026-$1,214ACRVChief Operating Officer Devroe Eric sold $1,214 worth of shares (604 units at $2.01), decreasing direct ownership by 0.41% to 146,349 units (for tax liability)Form 4Open-market sale
- May 18, 2026ACRVChief Operating Officer Devroe Eric was granted 72,981 shares, increasing direct ownership by 99% to 146,953 unitsForm 4Grant or award
- May 14, 2026ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 613 shares, decreasing direct ownership by 0.82% to 73,972 units (withholding obligation)Form 4Shares withheld for taxes or exercise price
- Mar 1, 2026ACRVSEC Form 4 filed by Chief Operating Officer Devroe EricForm 4Grant or award
- Feb 14, 2026ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 723 shares, decreasing direct ownership by 0.96% to 74,585 unitsForm 4Shares withheld for taxes or exercise price
- Jan 13, 2026+$17.2KACRVChief Operating Officer Devroe Eric bought $17,218 worth of shares (10,000 units at $1.72), increasing direct ownership by 15% to 75,308 unitsForm 4/AOpen-market purchase
- Nov 14, 2025ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 613 shares, decreasing direct ownership by 0.93% to 65,308 unitsForm 4Shares withheld for taxes or exercise price
- Aug 14, 2025ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 613 shares, decreasing direct ownership by 0.92% to 65,921 unitsForm 4Shares withheld for taxes or exercise price
- May 14, 2025ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 613 shares, decreasing direct ownership by 0.91% to 66,534 unitsForm 4Shares withheld for taxes or exercise price
- Mar 1, 2025ACRVSEC Form 4 filed by Chief Operating Officer Devroe EricForm 4Grant or award
- Feb 14, 2025ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 724 shares, decreasing direct ownership by 1% to 67,147 unitsForm 4Shares withheld for taxes or exercise price
- Mar 1, 2024ACRVSEC Form 4 filed by Chief Operating Officer Devroe EricForm 4Grant or award
- Nov 14, 2024ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 613 shares, decreasing direct ownership by 0.90% to 67,871 unitsForm 4Shares withheld for taxes or exercise price
- Aug 14, 2024ACRVChief Operating Officer Devroe Eric covered exercise/tax liability with 613 shares, decreasing direct ownership by 0.89% to 68,484 unitsForm 4Shares withheld for taxes or exercise price
- May 17, 2024ACRVDevroe Eric exercised 10,000 shares at a strike of $1.04, increasing direct ownership by 17% to 69,097 unitsForm 4Exercise or conversion of a derivative
- May 14, 2024ACRVDevroe Eric covered exercise/tax liability with 613 shares, decreasing direct ownership by 1% to 59,097 unitsForm 4Shares withheld for taxes or exercise price
Compare Eric Devroe with
- Eric Devroe vs Michaela Levin1 shared
- Eric Devroe vs Peter Blume-Jensen1 shared
- Eric Devroe vs Mary Miller1 shared
- Eric Devroe vs Katharine Peterson1 shared
- Eric Devroe vs Erick Gamelin1 shared
- Eric Devroe vs Adam D. Levy1 shared
Other insiders at the same companies
- Michaela LevinACRV
- Peter Blume-JensenACRV
- Mary MillerACRV
- Katharine PetersonACRV
- Erick GamelinACRV
- Adam D. LevyACRV
- Ra Capital Management, L.P.ACRV
- Michael John TomsicekACRV
- Sharon ShachamACRV
- Santhosh PalaniACRV
- Ivana Magovcevic-LiebischACRV
- Derek DiRoccoACRV
- Charles M BaumACRV
- Mansoor Raza MirzaACRV
- Perceptive Advisors LLCACRV
- Rasmus Holm-JorgensenACRV
Questions about Eric Devroe
- What is Eric Devroe's role at Acrivon Therapeutics, Inc.?
- Eric Devroe reports to the SEC as chief Operating Officer at Acrivon Therapeutics, Inc. (ACRV), according to the latest filing on August 20, 2026.
- How many shares does Eric Devroe own?
- After the latest filing that states it, Eric Devroe directly owned 146,349 shares of Acrivon Therapeutics, Inc. (ACRV). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric Devroe bought or sold stock recently?
- The most recent open-market purchase was on January 13, 2026: bought 10,000 shares of Acrivon Therapeutics, Inc. (ACRV) for $17.2K at an average of $1.72. The most recent open-market sale was on August 18, 2026: sold 604 shares of Acrivon Therapeutics, Inc. (ACRV) for $1,214 at an average of $2.01.
- How do I get alerts when Eric Devroe files?
- Follow Eric Devroe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Eric Devroe filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Eric Devroe (SEC CIK 0001950573). Totals count each trade once, skipping amendments whose original is on file, from May 16, 2024 on. View on SEC EDGAR